首页>
外国专利>
COMBINATION OF APO2L/TRAIL AND EGFR INHIBITOR FOR CANCER TREATMENT, METHOD IN VITRO OF APOPTOSIS INCREASE AND APPLICATION OF COMBINATION FOR OBTAINING MEDICATION FOR CANCER TREATMENT
COMBINATION OF APO2L/TRAIL AND EGFR INHIBITOR FOR CANCER TREATMENT, METHOD IN VITRO OF APOPTOSIS INCREASE AND APPLICATION OF COMBINATION FOR OBTAINING MEDICATION FOR CANCER TREATMENT
FIELD: medicine.;SUBSTANCE: in order to increase apoptosis in mammalian cells, combination, containing efficient amount of polypeptide Apo2L/TRAIL and EGFR inhibitor, representing N-(3-ethinylphenyl)-6,7-bis(2-methoxyetoxy)-4-chinasolinamine is used.;EFFECT: invention makes it possible to use combination efficiently to increase apoptosis, in which sinergetic activity of claimed composition is demonstrated.;15 cl, 12 dwg, 7 ex
展开▼
机译：领域：药物：为了增加哺乳动物细胞的凋亡，组合使用有效量的多肽Apo2L / TRAIL和EGFR抑制剂，代表N-（3-乙炔基苯基）-6,7-双（2-甲氧基乙氧基）-效果：使用本发明的组合物可以有效地使用组合物来增加细胞凋亡，其中证明了所要求保护的组合物的辛格活性; 15 cl，12 dwg，7 ex
展开▼
